Join Conscio Group and SigutLabs on April 22, 2026, at 2:00 PM CET for a focused session on how linker design, conjugation strategy, DAR control and integrated bioanalytical insight support better ADC development decisions.
As antibody-drug conjugates become more sophisticated, development success depends on more than payload potency alone. Linker properties, conjugation chemistry, DAR control and the ability to interpret complex in vivo behavior are all critical to building robust and competitive ADC programs.
This webinar will bring together expert perspectives from chemistry and bioanalysis to explore how these elements interact across development. From modulation of linker physical properties and conjugation strategy to DAR characterization, multi-analyte PK, immunogenicity assessment and intact mass spectrometry, the session will highlight the decisions that matter most when advancing complex ADC candidates.
Program highlights:
- The Organic Chemist’s Role in Enhancing ADC Performance
Speaker: Alessandro Panattoni, Head of Chemistry, SigutLabs - Navigating the Complexity of ADCs: Integrated Analytical and Bioanalytical Strategies for Next-Generation Biotherapeutics
Speaker: Milan Maděra, Head of Biologics Department, Conscio Group - Opening remarks & ADC market insights
Host: Jiří Raška, CCO, Conscio Group
Register here to secure your spot. Participation is free!
Whether you work in chemistry, analytical development, bioanalysis, CMC or cross-functional ADC programs, this webinar will offer practical insight into the decisions that influence candidate quality, development readiness and translational understanding. The session includes a live Q&A, giving participants the opportunity to engage directly with the speakers.
Interested in one of our previous expert webinar sessions? Watch the recording here: From Analytical Similarity to Clinical Data – Webinar Recording link
